Navigation Links
Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
Date:9/30/2008

FORT WORTH, Texas, Sept. 30 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it will attend and exhibit at the Wound Care Seminar: Clinical and Economical Realities in Boston. This seminar is presented by HMP Communications, the publishers of OWM, WOUNDS, Today's Wound Clinic, Podiatry Today and producers of the Symposium on Advanced Wound Care. The seminar will be attended by podiatrists, nurses, PT's, nursing home administrators, dieticians, and pharmacists who care for patients with wounds. The focus is on the clinical and economic perspective of wound care delivery in various sites of service.

"This seminar is an excellent opportunity for us to present our advanced wound care product, CellerateRx(R)," states Cathy Bradshaw, President of Wound Care Innovations. "CellerateRx(R) is FDA cleared for use on all wound types except for 3rd degree burns and is effective in all wound phases. It is biodegradable so it does not need to be removed from the wound and reapplication is 3 times per week or as needed. Fewer required dressing changes translates to lower staffing and material costs for the healthcare industry, for which wounds are becoming a major expense. In the United States alone, when additional costs associated with wound care morbidity are factored in, the total costs soar to over an estimated 200 billion annually. CellerateRx(R)'s performance and cost effectiveness is key element in today's healthcare environment. Being in attendance here allows us to present this information to a defined wound care market segment."

Additionally, Wound Care Technologies is continuing its plans to do expanded clinical research and evidence based studies on the mechanisms by which CellerateRx(R) affects factors crucial for wound healing. More details on this will be announced shortly.

About Wound Management Technologies, Inc.:

Wound Man
'/>"/>

SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
2. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
3. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
4. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
5. Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
6. Wound Management Technologies, Inc. Announces Evidence Based Study
7. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
8. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
11. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)..., , CHICAGO, Nov. 29 A...g of the Radiological Society of North America (RS...ace in Chicago , Siemens Healthcare will introduc...ventional oncology at booth #825, East Building/...ly invasive procedures for cancer therapy, the...
(Date:11/29/2009)..., , IOWA CITY, Iowa and ST. LOUIS, Nov. 2...loper of quantitative imaging software for the adv...dical Technologies, a leader in minimally invasive...nounced the companies have signed a definitive agr... of an endobronchial lung navigation and biopsy sy...
(Date:11/29/2009)..., , CHICAGO, Nov. 29 Stimula...ket leadership Fujifilm Medical Systems USA announ...erica (RSNA) annual meeting, the formation of its ... Networks Systems, this new group will integrate a...tics offering and creates a platform for future gr...
Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2Minimally Invasive Procedure for Oncology 3Minimally Invasive Procedure for Oncology 4Minimally Invasive Procedure for Oncology 5VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 1Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 2Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 3Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 4MRI Might Find Early Alzheimers 55180 1MRI Might Find Early Alzheimers 55180 2Trust in a teardrop 9687 1Trust in a teardrop 9687 2
...TON, N.J., March 25, 2007 /PRNewswire/ -- Once-dai...ation tolvaptan, a,vasopressin receptor antagonist...mptoms of acutely decompensated heart failure (ADH... care, without an,adverse effect on their long-ter...the short- and long-term analyses of the,internati...
...leeding in Patients Treated for Acute Coronary Syn...ne Year, NEW ORLEANS, March 26, 2007 /PRNewswire/ ...l show that acute coronary syndrome,(ACS) patients...t,group had similar rates of ischemic clinical out...apy, confirming previous findings,which showed si...
Other Medicine Technology:Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6
(Date:11/30/2009)...m The Healy Law Firm secure the highest pool-relat...endered an incomplete quadriplegic. , ..., 2009 -- A Cook County jury has entered an $8.1 m...enter, 22 years old at the time, who dove into a s...plegic. The verdict, which was reduced to $4,051,...
(Date:11/30/2009)...(NASDAQ OMX Copenhagen: “EXQ”) announc...wood Screening Facility (ICCB-L) has been recogniz...ICCB-L supports investigators at Harvard Medical S...for high-throughput screening of small molecule an...n, MA and Copenhagen, Denmark (PRWEB) November 30,...
(Date:11/30/2009)...vember 30 Simbionix USA Corporatio...tion systems, in collaboration,with GORE Medical P...dio(TM),workshop for the first time at the upcomin...he Simbionix PROcedure Rehearsal Studio(TM) is the...ans to create practice scenarios based on their,pa...
(Date:11/30/2009)... revealed that beverage can pull-tabs were being s...anufacturers to stay-tabs. But a study presented t...iety of North America (RSNA) found that the new ta...riving factors leading the change in beverage can ...ent swallowing of the pull-tab and potential relat...
(Date:11/30/2009)...stern Medical Center researchers have found that i...ations associated with asthma. The findings, avail...cs, suggest that interventions by parent mentors ...d specialized topical training can effectively re...ts and missed adult workdays. , "Childhood asthm...
Breaking Medicine News(10 mins):Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 4Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Beverage can stay-tabs pose swallowing risk 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2
...aries widely from state to state, with some states...stroke prevalence of others , according to a new r...vention (CDC). The report, "Prevalence of Stroke -...0 states, the District of Columbia and U.S. territ...
...n Malloy, critically injured in a car accident, sk...l her story. Doctors call her recovery a miracle....Her skull separated from her spine, although her s...ontrol over her head. Surgeons said her injur...
...am of researchers from the University of East Angl...-Planck Institute for Biogeochemistry have found ...rbon dioxide has reached a saturation point. ...has led to a release of stored CO2 into the atmosp...
...tandard regimen in most cancer treatments. Since i...re made to replace it with something more comfort...that LHRH agonists like the drug Zoladex switch of...king the action of a naturally occurring substance...
...as found that intake of cruciferous vegetables wit...otective benefit against bladder cancer. ...ciferous vegetables such as broccoli, cauliflower,...on of cytochrome p450 enzyme levels and provoke ap...
...ly affects to work, sleep and performance of other...r your memory and your concentration. Thi...nd Saifudin Rashiq at the University of Alberta. ...tients, two-thirds of whom showed significant disr...
Other Medicine News:Health News:Significant Differences in Stroke Prevalence Among U.S. States & Territories - CDC Report 2Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Risk of Bladder Cancer Reduced by Broccoli and Cauliflower 2Health News:Chronic Pain can Impair Memory and Concentration 2
Protector Collar
Serpentine Cervical Collar
...ipital Mandibular Immobilizer) A completely adjust...ral or hypertension positioning and immobilization...™ collar and a halo-type brace.,Mandibular ...ovable chin plate allows for patient eating and hy...
Ezy Wrap® Economy Contour Cervical Collar
Medicine Products: